[Abstract]:

On March 30, TIANS Group signed a strategic cooperation agreement with pharmaceutical industry of FIGO media in Suzhou. Peng Ting, vice president of TIANS group, expert consultant of pharmaceutical engineering editorial board of process industry and pharmaceutical industry, and Yang Qiong, project director of pharmaceutical industry, attended the signing ceremony on behalf of both parties. The two sides aim to complement each other in terms of pharmaceutical industry technology, expert team and media publicity, jointly promote technological development in China's pharmaceutical engineering field, build an industry media enterprise full coverage ecosystem, and lay the leading position of both sides in the industry.

Peng Ting said that as a leading enterprise in the pharmaceutical engineering industry, TIANS has built hundreds of landmark pharmaceutical engineering projects in China, with a strong team of technical experts and rich project practice experience, helping China's pharmaceutical industry to integrate with world standards. TIANS also hopes to work with the authoritative media in the industry, such as pharmaceutical industry, to empower each other, lead the technology, and unite with strong forces, so as to work hard for the development of the industry.

According to Yang Qiong, pharmaceutical industry has been founded in China for nearly 18 years, witnessing the growth of a number of new recruits into the backbone of the industry; witnessing the implementation of the new GMP and the take-off of China's pharmaceutical engineering and technical equipment; and experiencing the rapid integration of China's pharmaceutical industry with the world. Pharmaceutical industry's strategic cooperation with the times is bound to write a new chapter in the industry and create a bright future for China's pharmaceutical industry with a mature and steady pace.

For a long time, TIANS group has maintained cooperation with pharmaceutical industry and its parent magazine process industry in technology, experts and other dimensions. In December 2020, Peng Ting, vice president of TIANS group, and Qin Yi, deputy general manager of Shanghai Design and Research Institute of TIANS group, were employed as "expert consultant of editorial board of pharmaceutical engineering of process industry and pharmaceutical industry", which witnessed the high cooperation achievements of both sides in the field of Technology.

Peng Ting

Peng Ting, expert in pharmaceutical and chemical technology, vice president of TIANS group, general manager of chemical and pharmaceutical business department, member of TIANS science and Technology Committee.

He has a master's degree in bioengineering from Hebei University of technology. He has been deeply engaged in the field of chemistry and medicine for many years, and has rich experience in pharmaceutical and chemical process design and project management. We have organized and participated in the construction, relocation, upgrading and transformation projects of several domestic well-known pharmaceutical enterprises, and provided the whole process consulting and engineering design services in line with the industry regulations for many pharmaceutical enterprises with advanced design concepts. We have long been committed to the research and exploration of EPC project general contracting mode in the pharmaceutical and chemical industry.

Qin Yi

Structural design expert, deputy general manager of Shanghai Design and Research Institute of TIANS group.

Graduated from Tongji University, majored in construction engineering and information technology, has more than 15 years of engineering design and engineering management experience in the pharmaceutical industry. Its leading and participating projects include Heyuan Zhizao precision medical industry base construction project; Lepu biological monoclone PD-1 and PDL-1 industrialization project; Shanghai Baoji pharmaceutical recombinant protein drug industrialization project; Shanghai Junshi biotechnology industrialization port project; Changchun Jinsai pharmaceutical eukaryotic workshop project; Tianjin Changhe Biotechnology Co., Ltd. stem cell project, etc Superficial biochemical, OSD, injection and laboratory projects.

In the future, TIANS group will join hands with pharmaceutical industry to further build a model of cooperation, continuously broaden the scope and ideas of cooperation, continue to give full play to TIANS's industrial chain and talent advantages, create a new chapter of win-win development, and help the innovation and development of pharmaceutical ecosystem to a new level.